Real-time enrollment status for this hypertriglyceridemia clinical trial
Current Status
Recruiting
Checked: August 28, 2026 at 1:45 PM UTC
| NCT Number | NCT07604974 |
| Recruiting Status | Recruiting |
| Condition | Hypertriglyceridemia |
| Phase | PHASE2 |
| Target Enrollment | 72 participants |
| Active Locations | 15 sites in the US |
| Sponsor | Ionis Pharmaceuticals, Inc. |
| Last Updated on CT.gov | June 18, 2026 (Jun 18, 2026) |
As of August 28, 2026: Clinical trial NCT07604974 is currently recruiting participants. This phase2 study for hypertriglyceridemia is actively seeking new participants at 15 locations across the United States. The study is sponsored by Ionis Pharmaceuticals, Inc.. This status information is automatically verified from the official ClinicalTrials.gov registry.
Yes, NCT07604974 is actively recruiting participants as of August 28, 2026. You can check eligibility and apply through HelloStudys.
This trial is recruiting at 15 locations in the United States. View all available locations on the full study page.
Check your eligibility and express interest by completing the application form on the study page. A research coordinator will follow up to discuss next steps.
The official ClinicalTrials.gov record for NCT07604974 was last updated Jun 18, 2026 (June 18, 2026). HelloStudys verifies this status automatically.